Nema internetske veze — prikazuje se spremljena verzija stranice.

Amgen Inc

USUSD
← Na Filtar Dionica

Amgen Inc (LSE:0R0T) — Biotechnology: Biological Products (No Diagnostic Substances). Broj burzi na kojima se trguje dionicama tvrtke: 4. Na ovoj stranici — cijena i grafikon, dividende, najveći dioničari i povijest broja dionica.

O Tvrtki

Web-Stranica
amgen.com
Odnosi s Investitorima
investors.amgen.com/
Sektor
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Sjedište
Thousand Oaks, United States
Glavni Direktor
Robert A. Bradway
Zaposlenici
17 900
Osnovana
1980
Dionice u Optjecaju
540.63 mil. na dan 2026-07-30
Slobodno Prenosive Dionice
539.16 mil.
Tržišna Kapitalizacija
226.05 mlrd. USD
Insajderi
0.23%
Institucionalni Ulagači
85.02%
Djelatnost (SIC)
Biological Products, (No Diagnostic Substances)
Pravni Oblik
XTIQ
ISIN
US0311621009
LEI
62QBXGPJ34PQ72Z12S66
Omjer Isplate
60.4%
FCF
10.2 mlrd. USD
Isplata / FCF
52%
Dug
57.3 mlrd. USD
4.3 g. FCF
Dividendni Staž
15 g.
Zarada, FCF i isplaćene dividende — za 12 mjeseci do 30.06.2026 (najnovije izvješće tvrtke).
Opis

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including PROLIA, REPATHA, OTEZLA, ENBREL, EVENITY, XGEVA, TEPEZZA, BLINCYTO, NPLATE, TEZSPIRE, KYPROLIS, ARANESP, KRYSTEXXA AND VECTIBIX, MVASI, PAVBLU, UPLIZNA, IMDELLTRA/IMDYLLTRA, AMJEVITA/AMGEVITA, TAVNEOS, NEULASTA, LUMAKRAS/LUMYKRAS, RAVICTI, PARSABIV, AIMOVIG, WEZLANA/WEZENLA, AND PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; BEONE MEDICINES LTD. to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. The company was incorporated in 1980 and is headquartered in Thousand Oaks, California.

oglas

Burze i Oznake

BurzaOznakaValutaCijenaVrsta
US USA StocksAMGN glavnaUSD412.84 -1.13%obične dionice
HK Hong Kong Stock Exchange4332 dodatnaHKD—
LSE London Stock Exchange0R0T IOBUSD411.854 +1.17%obične dionice
MX Mexican Stock ExchangeAMGN dodatnaMXN7 500.0098 +0.00%obične dionice
XETRA XetraAMG dodatnaEUR367.95 -1.39%obične dionice

Cijena za 3 Mjeseca

dan rasta dan pada ex-dividendni datum datum isplatePrijeđite mišem / dodirnite dan — cijene otvaranja, zatvaranja, najviša i najniža

Dividende

Godišnje, US:AMGN: 9.94 USD (4 ispl.)

Amgen Inc (AMGN) isplaćuje dividende kvartalno. Godišnje (12 mjeseci do uključivo posljednje najavljene isplate): 9.94 USD po dionici (isplata: 4). To je otprilike 2.41% trenutne cijene dionice. Prema povijesti isplata, sljedeći datum ex-dividende očekuje se oko 20.11.2026. Godine neprekinutih dividendi: 15.

Ex-DatumIsplataIznos%VrstaOznaka
2026-08-212026-09-112.5200 USD0.6/2.3 %tromjesečnoUS:AMGN
2026-05-152026-06-052.5200 USD0.7/2.9 %tromjesečnoUS:AMGN
2026-02-132026-03-062.5200 USD0.7/2.6 %tromjesečnoUS:AMGN
2025-11-212025-12-122.3800 USD0.7/2.8 %tromjesečnoUS:AMGN
2025-08-222025-09-122.3800 USD0.8/3.2 %tromjesečnoUS:AMGN
2025-05-162025-06-062.3800 USD0.9/3.4 %tromjesečnoUS:AMGN
2025-02-142025-03-072.3800 USD0.8/3.1 %tromjesečnoUS:AMGN
2024-11-182024-12-092.2500 USD0.8/3.2 %tromjesečnoUS:AMGN
2024-08-162024-09-062.2500 USD0.5/2.2 %tromjesečnoUS:AMGN
2024-05-162024-06-072.2500 USD0.5/≈2.2 %tromjesečnoUS:AMGN
2024-02-152024-03-072.2500 USD0.5/≈2.2 %tromjesečnoUS:AMGN
2023-11-162023-12-082.1300 USD0.5/≈2.1 %tromjesečnoUS:AMGN

Najveći Imatelji

ImateljUdioDioniceDatum Izvješća
Blackrock Inc.9.13%49.36 mil.2026-06-30
Vanguard Capital Managem…6.52%35.25 mil.2026-06-30
State Street Corporation5.65%30.56 mil.2026-06-30
Capital World Investors5.38%29.08 mil.2026-06-30
VANGUARD INDEX FUNDS-Van…3.17%17.13 mil.2026-06-30
Invesco Ltd.3.02%16.32 mil.2026-06-30
Geode Capital Management…2.9%15.7 mil.2026-06-30
Charles Schwab Investmen…2.78%15.03 mil.2026-06-30
Vanguard Portfolio Manag…2.75%14.85 mil.2026-06-30
VANGUARD INDEX FUNDS-Van…2.59%13.99 mil.2026-06-30
Morgan Stanley2.53%13.65 mil.2026-06-30
Invesco QQQ Trust, Serie…2.15%11.61 mil.2026-08-31
SCHWAB STRATEGIC TRUST-S…1.81%9.79 mil.2026-05-31
Income Fund of America1.44%7.76 mil.2026-06-30
iShares Trust-iShares Co…1.35%7.28 mil.2026-07-31
Wells Fargo & Company1.34%7.24 mil.2026-06-30
AMERICAN BALANCED FUND1.31%7.09 mil.2026-06-30
Fidelity Concord Street…1.29%6.98 mil.2026-07-31
SPDR S&P 500 ETF TRUST-S…1.22%6.6 mil.2026-08-31
WASHINGTON MUTUAL INVEST…1.16%6.27 mil.2026-06-30
BRADWAY ROBERT A (Chief…≈0.12%657 2992026-05-05
SANTOS ESTEBAN (Officer)≈0.02%84 2792026-05-05
GORDON MURDO (Officer)≈0.01%51 8372026-05-05
GRIFFITH PETER H. (Chief…≈0.01%50 7062026-05-05
REESE DAVID M. (Chief Te…≈0.01%42 8122026-05-05
GRAHAM JONATHAN P (Gener…≈0.01%40 2112026-05-05
BRADNER JAMES E. (Office…≈0.01%30 4622026-05-05
ECKERT ROBERT ANDREW (Di…≈0%26 2512026-05-19
JACKS TYLER (Director)≈0%18 2842026-05-19
KULLMAN ELLEN JAMISON (D…≈0%14 5362026-05-19